These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16569974)
1. Hemostatic responses to resistance training in patients with coronary artery disease. deJong AT; Womack CJ; Perrine JA; Franklin BA J Cardiopulm Rehabil; 2006; 26(2):80-3. PubMed ID: 16569974 [TBL] [Abstract][Full Text] [Related]
2. Coagulation and fibrinolytic responses to manual versus automated snow removal. Womack CJ; Paton CM; Coughlin AM; Nagelkirk P; Dejong AT; Anderson J; Franklin BA Med Sci Sports Exerc; 2003 Oct; 35(10):1755-9. PubMed ID: 14523316 [TBL] [Abstract][Full Text] [Related]
3. Changes in von Willebrand factor and fibrinolysis following a post-exercise cool-down. Paton CM; Nagelkirk PR; Coughlin AM; Cooper JA; Davis GA; Hassouna H; Pivarnik JM; Womack CJ Eur J Appl Physiol; 2004 Jul; 92(3):328-33. PubMed ID: 15098129 [TBL] [Abstract][Full Text] [Related]
4. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026 [TBL] [Abstract][Full Text] [Related]
5. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction. Eriksson-Berg M; Egberg N; Eksborg S; Schenck-Gustafsson K Thromb Res; 2002 Mar; 105(6):481-6. PubMed ID: 12091046 [TBL] [Abstract][Full Text] [Related]
6. The effect of basal insulin glargine on the fibrinolytic system and von Willebrand factor in people with dysglycaemia and high risk for cardiovascular events: Swedish substudy of the Outcome Reduction with an Initial Glargine Intervention trial. Rautio A; Boman K; Gerstein HC; Hernestål-Boman J; Lee SF; Olofsson M; Mellbin LG Diab Vasc Dis Res; 2017 Jul; 14(4):345-352. PubMed ID: 28403644 [TBL] [Abstract][Full Text] [Related]
7. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. Bridges AB; McLaren M; Scott NA; Pringle TH; McNeill GP; Belch JJ Br Heart J; 1993 Feb; 69(2):121-4. PubMed ID: 8435236 [TBL] [Abstract][Full Text] [Related]
8. Effects of cardiac rehabilitation on fibrinolysis in patients with coronary artery disease. Anomasiri W; Thongthawee B J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S242-8. PubMed ID: 16623036 [TBL] [Abstract][Full Text] [Related]
9. Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. Mansfield MW; Heywood DM; Grant PJ Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):160-4. PubMed ID: 8548417 [TBL] [Abstract][Full Text] [Related]
11. Altered endothelial function following the Fontan procedure. Binotto MA; Maeda NY; Lopes AA Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358 [TBL] [Abstract][Full Text] [Related]
12. Human gender differences in fibrinolytic responses to exercise training and their determinants. Kulaputana O; Macko RF; Ghiu I; Phares DA; Goldberg AP; Hagberg JM Exp Physiol; 2005 Nov; 90(6):881-7. PubMed ID: 16118237 [TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction. Fernhall B; Szymanski LM; Gorman PA; Milani J; Paup DC; Kessler CM Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1106-13. PubMed ID: 9194761 [TBL] [Abstract][Full Text] [Related]
14. Regular Resistance Training Enhances Fibrinolytic Potential but Does Not Affect Coagulation. Nagelkirk PR; Soave K; Altherr C; Del Pozzi A Med Sci Sports Exerc; 2021 Nov; 53(11):2318-2323. PubMed ID: 34115732 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281 [TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic responses to moderate intensity exercise. Comparison of physically active and inactive men. Szymanski LM; Pate RR Arterioscler Thromb; 1994 Nov; 14(11):1746-50. PubMed ID: 7947599 [TBL] [Abstract][Full Text] [Related]
17. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551 [TBL] [Abstract][Full Text] [Related]
18. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients. Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149 [TBL] [Abstract][Full Text] [Related]
19. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Poli KA; Tofler GH; Larson MG; Evans JC; Sutherland PA; Lipinska I; Mittleman MA; Muller JE; D'Agostino RB; Wilson PW; Levy D Circulation; 2000 Jan; 101(3):264-9. PubMed ID: 10645922 [TBL] [Abstract][Full Text] [Related]